Pacira Pharmaceuticals reported $-693000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acelrx Pharmaceuticals ACRX:US USD -6750000 77.41M
Amerisourcebergen ABC:US USD 479.74M 185.01M
Astellas Pharma 4503:JP JPY 71.62B 46.81B
Bristol Myers Squibb BMY:US USD 2.02B 416M
Cara Therapeutics CARA:US USD -23180000 18.97M
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
Horizon Pharma HZNP:US USD 135.84M 74.86M
Ironwood Pharmaceuticals IRWD:US USD 50.32M 13.24M
JAZZ PHA JAZZ:US USD -19648000 54.31M
Johnson & Johnson JNJ:US USD 3.52B 938M
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Omeros OMER:US USD -17456000 13.39M
Pacira Pharmaceuticals PCRX:US USD -693000 20.57M
Perrigo Ordinary Shares PRGO:US USD -49400000 15.7M
Pfizer PFE:US USD 5B 3.61B
Revance Therapeutics RVNC:US USD -84693000 23.26M
Teva Pharmaceutical TEVA:IT USD 55M 288M
Xeris Pharmaceuticals Inc XERS:US USD -21831000 4.35M
Xoma XOMA:US USD -4178000 492K
Zoetis ZTS:US USD 529M 0